Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

about

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer

P2860

Q58780154-2EBE7B04-F1B7-4FB1-8792-0077286C81CC

P2860

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

Item

http://www.wikidata.org/entity/Q42735168

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

@en

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

@nl

type

Item

label

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

@en

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

@nl

prefLabel

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

@en

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

@nl

P1476

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

@en

P2093

Ana Pires

http://www.w3.org/2001/XMLSchema#string

Hiroki Yokota

http://www.w3.org/2001/XMLSchema#string

Hugo G Ferreira

http://www.w3.org/2001/XMLSchema#string

João F Raposo

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.

Fibroblast growth factor 23 and its receptors.

The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23.

Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis

Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.

Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial

Clinical relevance of FGF-23 in chronic kidney disease.

P304

53-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/GRSB.S4880

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20628536

http://www.w3.org/2001/XMLSchema#string

P932

2901635

http://www.w3.org/2001/XMLSchema#string

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

about

P2860

P2860

Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932